FGF2 and breast carcinoma: Similar to HRG, upon Fibroblast Growth Factor 2 (FGF2) stimulation, cellular motility—of a breast cancer cell line—was reduced after siRNA-mediated knockdown of MEMO1, relative to controls [1].